Sentinel lymph node mapping of the canine anal sac using lymphoscintigraphy: A pilot study

2018 ◽  
Vol 60 (3) ◽  
pp. 346-350 ◽  
Author(s):  
Daniel S. Linden ◽  
Robert Cole ◽  
D. Michael Tillson ◽  
Harry W. Boothe ◽  
Brad M. Matz
Keyword(s):  
Lymph Node ◽  
Pilot Study ◽  
Sentinel Lymph Node ◽  
Sentinel Lymph Node Mapping ◽  
Lymph Node Mapping ◽  
Anal Sac

Contrast‐Enhanced Ultrasound With Perflubutane for Sentinel Lymph Node Mapping in Cutaneous Melanoma: A Pilot Study

2018 ◽  
Vol 129 (5) ◽  
pp. 1117-1122 ◽  
Author(s):  
Caitlin Bertelsen ◽  
Kevin G. King ◽  
Mark Swanson ◽  
Vinay Duddalwar ◽  
Jon‐Paul Pepper
Keyword(s):  
Lymph Node ◽  
Pilot Study ◽  
Sentinel Lymph Node ◽  
Cutaneous Melanoma ◽  
Sentinel Lymph Node Mapping ◽  
Contrast Enhanced Ultrasound ◽  
Lymph Node Mapping ◽  
Contrast Enhanced

MR lymphography with superparamagnetic iron oxide for sentinel lymph node mapping of N0 early oral cancer: A pilot study

2020 ◽  
pp. 20200333
Author(s):  
Satomi Sugiyama ◽  
Toshinori Iwai ◽  
Junichi Baba ◽  
Senri Oguri ◽  
Toshiharu Izumi ◽  
...  
Keyword(s):  
Lymph Node ◽  
Iron Oxide ◽  
Pilot Study ◽  
Sentinel Lymph Node ◽  
Oral Cancer ◽  
Superparamagnetic Iron Oxide ◽  
Sentinel Lymph Node Mapping ◽  
Lymph Node Mapping ◽  
Scanning Imaging ◽  
Ct Lymphography

Objectives: The purpose of this pilot study was to evaluate the usefulness of magnetic resonance lymphography (MRL) with superparamagnetic iron oxide (SPIO) in sentinel lymph node (SLN) mapping of clinically N0 early oral cancer, and to conduct a comparative study of this MRL with CT lymphography (CTL). Methods: CTL and MRL were performed for SLN mapping before surgery for 20 patients with clinically N0 early oral cancer. The detection rate, number, and location of SLNs in CTL and MRL were evaluated. Furthermore, optimal scanning/imaging timing in MRL was examined. Results: SLNs were detected by CTL in 18 (90%) patients, and the total and mean number of SLN were 35 and 1.8, respectively. All SLNs could be detected 2 min and 3.5–5 min after contrast medium injection. In all patients, SLNs were detected by MRL at 10 min after SPIO injection, and the total and mean number of SLN was 53 and 2.7, respectively. MRL at 30 min after the injection showed additional 18 secondary lymph nodes. Conclusion: MRL with SPIO is safe and useful imaging for the detection of SLNs in clinically N0 early oral cancer, and the optimal imaging timing is 10 min after SPIO injection.

Sign in / Sign up

Export Citation Format

Share Document